|
CGEM Cullinan Therapeutics Inc 1789972 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-219,879,000.00 |
| Balance Sheet |
|
Current Assets
|
$341,974,000.00 |
|
Assets
|
$363,787,000.00 |
|
Current Liabilities
|
$40,628,000.00 |
|
Liabilities
|
$42,033,000.00 |
|
Equity
|
$408,730,000.00 |
|
Shares Out
|
64345770.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-84,264,000.00 |
|
Investing Cash Flow
|
$73,092,000.00 |
| Market Analysis |
Market Cap
|
$1,375,712,562.60 |
|
Price
|
$21.38 |
|
BVPS
|
6.35 |
|
PB
|
3.37 |
|
EPS
|
-0.69 |
|
FCF
|
$-84,313,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-0.77 |
|
|
2026-05-07 |
-0.75 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.07 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.77 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CGEM documents filed with the SEC.
CGEM Filings
Clear
